Achieving Targeted Treatment Outcomes in IBD - Episode 4

Implementing Treat to Target in the Long-term in Inflammatory Bowel Disease

Published on: July 5, 2024

Silvio Danese, MD, PhD , Bruce Sands, MD , Jean-Frederic Colombel, MD

Expert panelists discuss the implementation of a treat-to-target approach for the long-term management of inflammatory bowel disease (IBD), drawing upon data from the STARDUST and REACT-2 trials to support their recommendations and insights into optimizing patient outcomes through this strategy.

EP. 1: Treat-to-target in Inflammatory Bowel Disease

EP. 3: Transmural Healing and Monitoring in Ulcerative Colitis and Crohn’s Disease

Now Viewing

EP. 4: Implementing Treat to Target in the Long-term in Inflammatory Bowel Disease

EP. 5: Suboptimal Treatment of Inflammatory Bowel Disease in Clinical Practice

EP. 6: Unmet Needs and Starting Advanced Treatment in Inflammatory Bowel Disease

EP. 7: Considerations for Choosing Advanced Treatments and Setting Patient Expectations

EP. 8: Combination Therapy in Inflammatory Bowel Disease

EP. 9: Measuring Patient Satisfaction with Inflammatory Bowel Disease Treatments and Communication Regarding Treatment Changes